BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36905338)

  • 1. A nationwide propensity score analysis comparing ablation and resection for hepatocellular carcinoma.
    Rasic G; de Geus SWL; Beaulieu-Jones B; Kasumova GG; Kent TS; Ng SC; McAneny D; Tseng JF; Sachs TE
    J Surg Oncol; 2023 Jun; 127(7):1125-1134. PubMed ID: 36905338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer Database.
    Uhlig J; Sellers CM; Stein SM; Kim HS
    Eur Radiol; 2019 May; 29(5):2679-2689. PubMed ID: 30560364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical resection versus ablation for hepatocellular carcinoma ≤ 3 cm: a population-based analysis.
    Miura JT; Johnston FM; Tsai S; Eastwood D; Banerjee A; Christians KK; Turaga KK; Gamblin TC
    HPB (Oxford); 2015 Oct; 17(10):896-901. PubMed ID: 26228076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤ 2  cm in a Propensity Score Model.
    Liu PH; Hsu CY; Hsia CY; Lee YH; Huang YH; Chiou YY; Lin HC; Huo TI
    Ann Surg; 2016 Mar; 263(3):538-45. PubMed ID: 25775062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small Hepatocellular Carcinoma: Radiofrequency Ablation versus Nonanatomic Resection--Propensity Score Analyses of Long-term Outcomes.
    Kang TW; Kim JM; Rhim H; Lee MW; Kim YS; Lim HK; Choi D; Song KD; Kwon CH; Joh JW; Paik SW; Paik YH; Ahn JH
    Radiology; 2015 Jun; 275(3):908-19. PubMed ID: 25688888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic Hepatectomy (with or without Robotic Assistance) versus Radiofrequency Ablation as a Minimally Invasive Treatment for Very Early-Stage or Early-Stage Hepatocellular Carcinoma.
    Chong CC; Lee KF; Chu CM; Chan AW; Yu SC; Lai PB
    Dig Surg; 2020; 37(1):65-71. PubMed ID: 30917378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albumin-bilirubin grade predicts the outcomes of liver resection versus radiofrequency ablation for very early/early stage of hepatocellular carcinoma.
    Chong CC; Chan AW; Wong J; Chu CM; Chan SL; Lee KF; Yu SC; To KF; Johnson P; Lai PB
    Surgeon; 2018 Jun; 16(3):163-170. PubMed ID: 28807570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
    Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
    J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical resection versus ablation for early-stage hepatocellular carcinoma: A retrospective cohort analysis.
    Lee GC; Ferrone CR; Vagefi PA; Uppot RN; Tanabe KK; Lillemoe KD; Blaszkowsky LS; Qadan M
    Am J Surg; 2019 Jul; 218(1):157-163. PubMed ID: 30635211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
    Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
    Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resection vs. ablation for alpha-fetoprotein positive hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
    He W; Li B; Zheng Y; Zou R; Shen J; Cheng D; Tao Q; Liu W; Li Q; Chen G; Yuan Y
    Liver Int; 2016 Nov; 36(11):1677-1687. PubMed ID: 27187721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
    Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
    Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local Ablation Does Not Worsen Perioperative Outcomes After Liver Transplant for Hepatocellular Carcinoma.
    de Haas RJ; Lim C; Ricci C; Lahat E; Fuentes L; Salloum C; Azoulay D
    AJR Am J Roentgenol; 2019 Sep; 213(3):702-709. PubMed ID: 31120785
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
    Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
    BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microwave ablation versus surgical resection for subcapsular hepatocellular carcinoma: a propensity score-matched study of long-term therapeutic outcomes.
    Liu K; Zheng H; Sui X; Liu B; Meng M; Feng Y; Zhu Q; Zhao X
    Eur Radiol; 2023 Mar; 33(3):1938-1948. PubMed ID: 36114849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated Hepatic Resection versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Hepatic Resection: A Propensity Score Matching Study.
    Song KD; Lim HK; Rhim H; Lee MW; Kim YS; Lee WJ; Paik YH; Gwak GY; Kim JM; Kwon CH; Joh JW
    Radiology; 2015 May; 275(2):599-608. PubMed ID: 25559235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early recurrence of hepatocellular carcinoma in patients after ablation and resection: A propensity score analysis.
    Wu Z; Zeng Y; Yuan Y; Shi Y; Qiu J; Li B; Yuan Y; He W
    Am J Surg; 2024 Feb; 228():94-101. PubMed ID: 37580221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic resection versus operative microwave ablation for single hepatocellular carcinoma ≤5 cm: A propensity score-matched analysis.
    Ryu T; Takami Y; Wada Y; Hara T; Sasaki S; Saitsu H
    Surgery; 2019 Sep; 166(3):254-262. PubMed ID: 31279438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncompromised treatment efficacy in elderly patients with hepatocellular carcinoma: a propensity score analysis.
    Liu PH; Hsu CY; Lee YH; Hsia CY; Huang YH; Su CW; Chiou YY; Lin HC; Huo TI
    Medicine (Baltimore); 2014 Dec; 93(28):e264. PubMed ID: 25526453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
    Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.